The promise of stem cell (SC) therapies to restore functions of damaged tissues and organs
brings enormous hope to patients, their families, loved ones, and caregivers. However, limits …

The availability of multiple disease-modifying medications with regulatory approval to treat
multiple sclerosis illustrates the substantial progress made in therapy of the disease …

Clarifying Stem-Cell Therapy’s Benefits and Risks | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …

The rationale for implantation of autologous human Schwann cells (SCs) in persons with
subacute spinal cord injury (SCI) is based on evidence that transplanted SCs are …

Abstract Background/Objective For patients with disorders of consciousness (DoC) and their
families, the search for new therapies has been a source of hope and frustration. Almost all …

Balancing Safety and Innovation for Cell-Based Regenerative Medicine | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

Pluripotent stem cells offer the potential for an unlimited source for cell therapy products.
However, there is concern regarding the tumorigenicity of these products in humans, mainly …

Background Regenerative medicine has the potential to treat genetic disorders and replace
damaged or missing tissue. The use of donor or animal tissue raises many well-known …

The development of cells for regenerative therapy has encountered many pitfalls on its path
to clinical translation. In cardiology, clinical studies of heart-targeted cell therapies began …

The main objective of this phase I trial was to assess the feasibility and safety of
microtransplanting human neural stem cell (hNSC) lines into the spinal cord of patients with …